Pharmacokinetic validation of neoral absorption profiling

被引：80

作者：

Johnston, A

David, OJ

Cooney, GF

机构：

[1] St Bartholomews Hosp, London, England

[2] Temple Univ Hosp, Philadelphia, PA 19140 USA

来源：

TRANSPLANTATION PROCEEDINGS | 2000年 / 32卷 / 3A期

关键词：

D O I：

10.1016/S0041-1345(00)00864-2

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

[No abstract available]

引用

页码：53S / 56S

页数：4

共 13 条

[1] CANTAROVICH M, 1998, TRANSPLANTATION, V65, P89
[2] Comparative bioavailability of neoral and sandimmune in cardiac transplant recipients over 1 year
Cooney, GF
Jeevanandam, V
Choudhury, S
Feutren, G
Mueller, EA
Eisen, HJ
[J]. TRANSPLANTATION PROCEEDINGS, 1998, 30 (05) : 1892 - 1894
[3] Peak cyclosporine levels (Cmax) correlate with freedom from liver graft rejection -: Results of a prospective, randomized comparison of neoral and sandimmune for liver transplantation (NOF-8)
Grant, D
Kneteman, N
Tchervenkov, J
Roy, A
Murphy, G
Tan, A
Hendricks, L
Guilbault, N
Levy, G
[J]. TRANSPLANTATION, 1999, 67 (08) : 1133 - 1137
[4] HALLORAN P, 1998, NEW STRATEGIES THERA
[5] The temporal profile of calcineurin inhibition by cyclosporine in vivo
Halloran, PF
Helms, LMH
Kung, L
Noujaim, J
[J]. TRANSPLANTATION, 1999, 68 (09) : 1356 - 1361
[6] JOHNSTON A, 1990, TRANSPLANT P, V22, P1345
[7] Johnston A, 1996, Transpl Int, V9 Suppl 1, pS305, DOI 10.1111/j.1432-2277.1996.tb01636.x
[8] KAHAN BD, 1995, TRANSPLANTATION, V59, P505
[9] INFLUENCE OF CYCLOSPORINE PHARMACOKINETICS, TROUGH CONCENTRATIONS, AND AUC MONITORING ON OUTCOME AFTER KIDNEY-TRANSPLANTATION
LINDHOLM, A
KAHAN, BD
[J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1993, 54 (02) : 205 - 218
[10] Neoral monitoring by simplified sparse sampling area under the concentration-time curve - Its relationship to acute rejection and cyclosporine nephrotoxicity early after kidney transplantation
Mahalati, K
Belitsky, P
Sketris, I
West, K
Panek, R
[J]. TRANSPLANTATION, 1999, 68 (01) : 55 - 62

← 1 2 →